Andrea Hunklinger

Andrea Hunklinger

Auto-generated profile, based on publicly available information

Andrea Hunklinger

Centre for Genomic Regulation, The Barcelona Institute of Science and Technology, Barcelona, Spain

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 May 2026 in Nature Machine Intelligence
Verified
Journal Article
Closed access
PDF file
AHAndrea Hunklinger
Andrea Hunklinger
NFNOELIA FERRUZ
NOELIA FERRUZ

11 April 2026 in Nature Communications
Verified
Journal Article
Open access
PDF file
THTim Hörmann
Tim Hörmann
DMDomenic Mayer
Domenic Mayer
MLMax Lewandowski
Max Lewandowski
AHAndrea Hunklinger
Andrea Hunklinger
TWThomas Wein
Thomas Wein
DMDaniel Merk
Daniel Merk
Automating structural optimization of drug molecules for on-target potency by machine learning is an open challenge in chemistry. Here, we capitalize on the ability of chemical language models (CLMs) to learn from sequential data and design new molecules with desired properties. We establish a training strategy mimicking the learning trajectory of a drug discovery program. Incremental CLM fine-tuning with increasingly potent template molecules from a given structure-activity relationship (SAR) series successfully biases the model to design highly active analogues. Prospective application of this technique to ligand development enables the data-driven design of molecules exceeding known representatives of given bioactive chemotypes in potency without external scoring. Our results reveal an ability of CLMs to capture SAR patterns and long-range dependencies, and to exploit SAR knowledge in designing analogues with improved on-target activity de novo corroborating their applicability to structural optimization of drug molecules.